Sichuan University

About: Sichuan University is a education organization based out in Chengdu, China. It is known for research contribution in the topics: Catalysis & Population. The organization has 107623 authors who have published 102844 publications receiving 1612131 citations. The organization is also known as: Sìchuān Dàxué.

Carbon Anode Materials for Advanced Sodium-Ion Batteries

Abstract: The ever-increasing demand of lithium-ion batteries (LIBs) caused by the rapid development of various electronics and electric vehicles will be hindered by the limited lithium resource. Thus sodium-ion batteries (SIBs) have been considered as a promising potential alternative for LIBs owing to the abundant sodium resource and similar electrochemical performances. In recent years, significant achievements regarding anode materials which restricted the development of SIBs in the past decades have been attained. Significantly, the sodium storage feasibility of carbon materials with abundant resource, low cost, nontoxicity and high safety has been confirmed, and extensive investigation have demonstrated that the carbonaceous materials can become promising electrode candidates for SIBs. In this review, the recent progress of the sodium storage performances of carbonaceous materials, including graphite, amorphous carbon, heteroatom-doped carbon, and biomass derived carbon, are presented and the related sodium storage mechanism is also summarized. Additionally, the critical issues, challenges and perspectives are provided to further understand the carbonaceous anode materials.

Bridging the g-C3N4 Interlayers for Enhanced Photocatalysis

Abstract: Graphitic carbon nitride (g-C3N4) has been widely investigated and applied in photocatalysis and catalysis, but its performance is still unsatisfactory. Here, we demonstrated that K-doped g-C3N4 with a unique electronic structure possessed highly enhanced visible-light photocatalytic performance for NO removal, which was superior to Na-doped g-C3N4. DFT calculations revealed that K or Na doping can narrow the bandgap of g-C3N4. K atoms, intercalated into the g-C3N4 interlayer via bridging the layers, could decrease the electronic localization and extend the π conjugated system, whereas Na atoms tended to be doped into the CN planes and increased the in-planar electron density. On the basis of theoretical calculation results, we synthesized K-doped g-C3N4 and Na-doped g-C3N4 by a facile thermal polymerization method. Consistent with the theoretical prediction, it was found that K was intercalated into the space between the g-C3N4 layers. The K-intercalated g-C3N4 sample showed increased visible-light absor...

High-throughput synthesis of single-layer MoS2 nanosheets as a near-infrared photothermal-triggered drug delivery for effective cancer therapy.

Abstract: We report here a simple, high-yield yet low-cost approach to design single-layer MoS2 nanosheets with controllable size via an improved oleum treatment exfoliation process. By decorating MoS2 nanosheets with chitosan, these functionalized MoS2 nanosheets have been developed as a chemotherapeutic drug nanocarrier for near-infrared (NIR) photothermal-triggered drug delivery, facilitating the combination of chemotherapy and photothermal therapy into one system for cancer therapy. Loaded doxorubicin could be controllably released upon the photothermal effect induced by 808 nm NIR laser irradiation. In vitro and in vivo tumor ablation studies demonstrate a better synergistic therapeutic effect of the combined treatment, compared with either chemotherapy or photothermal therapy alone. Finally, MoS2 nanosheets can also be used as a promising contrast agent in X-ray computed tomography imaging due to the obvious X-ray absorption ability of Mo. As a result, the high-throughput oleum treatment exfoliation process could be extended for fabricating other 2D nanomaterials, and the NIR-triggered drug release strategy was encouraging for simultaneous imaging-guided cancer theranostic application.

Targeting PI3K in cancer: mechanisms and advances in clinical trials

Abstract: Phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling is one of the most important intracellular pathways, which can be considered as a master regulator for cancer. Enormous efforts have been dedicated to the development of drugs targeting PI3K signaling, many of which are currently employed in clinical trials evaluation, and it is becoming increasingly clear that PI3K inhibitors are effective in inhibiting tumor progression. PI3K inhibitors are subdivided into dual PI3K/mTOR inhibitors, pan-PI3K inhibitors and isoform-specific inhibitors. In this review, we performed a critical review to summarize the role of the PI3K pathway in tumor development, recent PI3K inhibitors development based on clinical trials, and the mechanisms of resistance to PI3K inhibition.